Mahidol University: COVID-19 trials

The registry lists 12 COVID-19 studies with Mahidol University as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 4Phase 3 1Phase 4 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effectiveness of a Health Promotion Program for Older People With Post-Covid-19 SarcopeniaNot yet recruitingNCT06211686Not applicable
• Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 SymptomsStatus unknownNCT05484700
• Intradermal Tozinameran for Patients With Immune-mediated Dermatologic DiseasesCompletedNCT05406908Phase 4
• Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in ThailandCompletedNCT05328479
• Cardiac Manifestation in Adolescent After Pfizer COVID-19 Injection in ThailandCompletedNCT05288231
• Ivermectin With Favipiravir in Mild-to-moderate COVID-19 PatientsStatus unknownNCT05155527Phase 2
• Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 VaccineStatus unknownNCT05109559Phase 1/2
• Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 VaccineCompletedNCT05049226Phase 2
• The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok CommunityCompletedNCT05047900Not applicable
• Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19Status unknownNCT05019326Phase 3
• Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in ThailandCompletedNCT04764422Phase 1/2
• Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 InfectionStatus unknownNCT04435587Phase 4